Zhen Pan
Director/Board Member at SHANGHAI GUIJIU CO.,LTD
Profile
Zhen Pan is currently working as a Director at Shanghai Guijiu Co., Ltd.
and as a Member-Supervisory Board at Hebei Yipin Pharmaceutical Co., Ltd.
He holds a Master's degree in Business Administration from Shanghai Jiao Tong University and an undergraduate degree from Shanghai University of Finance & Economics.
Zhen Pan active positions
Companies | Position | Start |
---|---|---|
SHANGHAI GUIJIU CO.,LTD | Director/Board Member | 2021-08-31 |
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Director/Board Member | 2021-02-28 |
Training of Zhen Pan
Shanghai Jiao Tong University | Masters Business Admin |
Shanghai University of Finance & Economics | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
SHANGHAI GUIJIU CO.,LTD | Consumer Non-Durables |
Private companies | 1 |
---|---|
Hebei Yipin Pharmaceutical Co., Ltd.
Hebei Yipin Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Hebei Yipin Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of chemical preparation, and active pharmaceutical ingredients. Its products include urapidil hydrochloride injection, sevoflurane for inhalation, ropivacaine hydrochloride injection, pantoprazole sodium injection, esomeprazole sodium injection, and ornithine aspartate injection. It also offers compound a-ketoacid active pharmaceutical ingredients. The company was founded on May 29, 2013 and is headquartered in Shijiazhuang, China. | Health Technology |
- Stock Market
- Insiders
- Zhen Pan